quarterlife

Virus DNA found in cancer cells

February 6, 2020
Business Services Cancer, Cancer Virus, HPV, cancer research

The first comprehensive survey of viruses found with different types of cancer has been conducted by researchers. Researchers from the …

laboratory-analysis-diagnostics-hospital

Landmark study set to transform cancer treatment

February 6, 2020
Business Services Cancer, cancer breast, cancer mutations, cancer research, cancer treatment

Over a thousand scientists have built the most detailed picture of cancer ever in a landmark study. Their research was …

shutterstock_274590824

Biogen stock surges following patent victory over Mylan for Tecfidera

February 6, 2020
Sales and Marketing Biogen, Mylan, multiple sclerosis, pharma, tecfidera

Biogen has emerged victorious in a patent dispute with Mylan relating to the latter’s multiple sclerosis therapy Tecfidera – a …

small-1908307_1280

Newborn baby diagnosed with coronavirus

February 6, 2020
Business Services China disease, Chinese Coronavirus, MERS, Sars, Wuhan Coronavirus, coronavirus

A baby born this month in Wuhan China has been diagnosed with the coronavirus. The child was born 2 February, …

How AI is making clinical trials more accurate and affordable

February 5, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, AI Clinical Trials, Apple, Apple Watch., apple watch, clinical trials

Clinical trials are one of the longest and most expensive steps of bringing a drug to market. Conor Kavanagh investigates …

NICE plans to use broader range of data in guidance

February 5, 2020
Research and Development NHS, NHS NICE, NICE

The British National Institute for Care Excellence has said it plans to use a broader range of data and analytics …

Bayer’s Eylea shows strong vision benefits across two regimens in post-marketing study

February 5, 2020
Research and Development Bayer, Eylea, pharma

Bayer has pulled back the curtain on new Phase 4 data for Eylea (aflibercept), revealing strong findings in the treatment …

white-passenger-plane-on-airport-during-daytime

Final UK flight from Wuhan to bring home Britons from coronavirus epicenter

February 5, 2020
Research and Development Wuhan Coronavirus, Wuhan Virus, china coronavirus, coronavirus

The last flight from Wuhan will arrive back in the UK on Sunday, bringing back British nationals fleeing from the …

holly_springs_9frontflags

Seqirus’ Audenz becomes first FDA-approved cell-based adjuvant influenza A vaccine

February 5, 2020
Research and Development, Sales and Marketing FDA, influenza, pharma, seqirus

The FDA has just approved the first adjuvanted, cell-based vaccine for the prevention of influenza A (H5N1) in the US, …

assorted-condoms

Funding cuts and government inaction has led to soaring STI rates in Britain, new study finds

February 5, 2020
Research and Development AIDS, HIV, STDs, STIs, UK, sexual health

The UK faces a new Sexually Transmitted Infection (STI) diagnoses every 70 seconds, according to a new report that outlines …

New study casts doubt on effectiveness of psychotherapy treatments for military-related PTSD

February 4, 2020
Manufacturing and Production PTSD, PTSD Iraq, PTSD Therapy, PTSD WAR, PTSD military

A recent review of clinical trials shows that first-line psychotherapies are limited in how effectively they treat veterans with PTSD.

Europe’s CHMP recommends Pfizer’s biosimilar of Roche’s MabThera

February 4, 2020
Manufacturing and Production, Sales and Marketing MabThera, Pfizer, Ruxience, biosimilar, pharma

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has revealed that it has awarded a positive opinion for …

4693137_9f97577e

Sanofi charged in birth defects case in France

February 4, 2020
Manufacturing and Production Sanofi, Sanofi Birth Defects, Sanofi France

Sanofi has been charged with failure to adequately warn patients about their anti-epilepsy drug which has been linked to birth …

National Institutes of Health terminates HIV vaccine after it proves ineffective

February 4, 2020
Manufacturing and Production HIV, pharma

A trial investigating the efficacy  of a new HIV vaccine conducted by the National Institute of Allergy and Infectious Diseases …

mercado_de_mariscos_de_wuhan_cerrado_tras_detectarse_ahi_por_primera_vez_el_nuevo_coronavirus_

China admits its coronavirus response had “shortcomings”

February 4, 2020
Manufacturing and Production China, MERS, Sars, Wuhan, china coronavirus, coronavirus, wuihan coronavirus

In a rare move, China’s leadership has admitted “shortcomings” in the way it has handled the outbreak of the deadly …

Insider Interview: Reducing the risk of adverse cardiovascular events

February 3, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Insider Interview, cardiovascular, heart disease, pharma

Rodrigo Gribble, Vice President Cardiovascular at AstraZeneca, breaks down recently published data from the PEGASUS trial of ticagrelor, a potential …

gilead-sciences

Gilead’s experimental Ebola drug being tested in patients infected with coronavirus

February 3, 2020
Sales and Marketing Coronavirus Wuhan, MERS, Sars, Wuhan, coronavirus, coronavirus China

China and the US are testing Gilead’s remdesivir in patients with the coronavirus, in the hopes of developing an effective …

humacao_exterior

BMS pulls Opdivo+Yervoy combo in EU for advanced non-small cell lung cancer

February 3, 2020
Sales and Marketing BMS, Cancer, Europe, Yervoy, lung cancer, opdivo

Bristol-Myers Squibb has confirmed it has withdrawn its application with the European Commission for its combination of Opdivo (nivolumab) and …

mercado_de_mariscos_de_wuhan_cerrado_tras_detectarse_ahi_por_primera_vez_el_nuevo_coronavirus_

More Britons evacuated from Wuhan as UK donates £20 million to speed up vaccine

February 3, 2020
Sales and Marketing China virus, MERS, Sars, Wuhan Coronavirus, coronavirus, coronavirus China

More Britons have been flown back from Wuhan, the heart of the coronavirus outbreak, while the UK government has donated …

abbvie_0

AbbVie’s Venclyxto pins down CHMP approval for treatment-naive chronic lymphocytic leukaemia

February 3, 2020
Sales and Marketing AbbVie, CHMP, EMA, Venclyxto, pharma

The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has awarded recommendation to AbbVie’s Venclyxto (venetoclax), …

The Gateway to Local Adoption Series

Latest content